The first detectable bone abnormality in mild CKD not associated with renal Fanconi syndrome is an increased expression in the number of sclerostin and FGF23-expressing osteocytes, causing progressive elevations in the plasma concentrations of these bone-derived factors [41,42,43]. This evidence concerns the gene FGF23 and chronic kidney disease.